Issue of these options was dependent on the commercial project with CSIRO being deemed commercially viable after the following 2 points being met....
The last investor presentation mentioned that they were working towards making 100kg of Lidocaine Sulphate and they were engaging manufacturers to secure a commercial deal in FY20.
It looks like a license agreement may be sooner rather than later...
Issue of these options was dependent on the commercial project...
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.5¢ |
Change
0.005(1.09%) |
Mkt cap ! $52.38M | |||
| Open | High | Low | Value | Volume |
| 45.5¢ | 46.5¢ | 44.5¢ | $18.05K | 39.48K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 8691 | 44.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.5¢ | 14815 | 3 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| MVP (ASX) Chart |